HOME >> BIOLOGY >> NEWS
Florida frontier expedition

FT. PIERCE, Fla., May 20, 2004 -- Scientists from the new state-funded Center of Excellence in Biomedical and Marine Biotechnology will spend the next two weeks exploring never before seen sections of deepwater coral reefs rich with life off Florida's east coast and the Keys. The team, with members from Harbor Branch Oceanographic and Florida Atlantic University, will be using Harbor Branch's Johnson-Sea-Link I submersible and scuba in a search for marine creatures that produce chemicals with the potential to cure human diseases ranging from cancer to Alzheimer's.

Amazingly, vast stretches of vibrant seafloor lay unexplored just a few miles from major ports such as Miami, and the team expects to make important discoveries as they tap these previously hidden biomedical treasure troves for the first time. FAU's Department of Ocean Engineering has been using an unmanned autonomous underwater vehicle (AUV) to map the area and has discovered some of the promising sites that will be explored using the submersible. Regular dispatches from the expedition and photos will be posted at Harbor Branch's @Sea website, www.at-sea.org.

"Based on past work we have every reason to believe that there are cures waiting in Florida waters for a number of diseases, the only limitation has been financial," says Dr. Amy Wright, director of Harbor Branch's Biomedical Marine Research program and a co-leader of the expedition. "Funding like this for the Center of Excellence is essential for pushing this research and Florida's marine biotechnology industry forward."

Similar expeditions by Harbor Branch off Florida and around the world have already yielded numerous chemicals that show great promise in fighting cancer, infections, and other afflictions. One, a compound called discodermolide, has proven an effective cancer cell killer, even in tumors that are resistant to Taxol, one of the best treatments currently available for breast a
'"/>

Contact: Mark Schrope
schrope@hboi.edu
772-216-0390
Harbor Branch Oceanographic Institution
17-May-2004


Page: 1 2 3

Related biology news :

1. Tracing genes, biologists show lizard migration is traced to Florida
2. Florida Tech earns $50,000 grant to create coral database
3. Florida Tech researchers win $912,700 grant for cell studies
4. Exploring the sights and sounds of a deepwater coral marine protected area off Florida
5. Black water turns the tide on Florida coral
6. UCF to host Florida Academy of Sciences meeting
7. Coral smothering green tide seaweed spreading on Florida reefs
8. University of Florida engineers probe shape memory alloy for better prostheses
9. Common bacteria kills elkhorn coral off Florida keys, says UGA research team
10. University of South Florida team conducts trial for HIV vaccine
11. People and fire at Floridas wildland-urban interface

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Florida frontier expedition

(Date:11/3/2014)... Research and Markets has announced the addition of a ... to their offering. This report describes ... started to play an important role in the practice of ... bone marrow transplants. Role of cells in drug discovery is ... of medical practice. Stem cells are discussed in ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... , James Dacey explores the ways in which physicists ... innovations from the lab into the commercial market. , ... companies as they move from prototype to product is ... physics-based inventions are usually far from market-ready when initially ... lot more complicated than had been originally thought. , ...
Breaking Biology News(10 mins):Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2
(Date:11/21/2014)... York, NY (PRWEB) November 20, 2014 ... is now available as an open access journal featuring ... with infrared fluorescent proteins to preserve photoresponsiveness in the ... Two-color fluorescent in situ hybridization using chromogenic substrates ... chips for DNA, RNA, and protein electrophoresis , ...
(Date:11/21/2014)... 21, 2014 2014 Deep Research ... is a professional and in-depth research report on ... information, like its definition, classification, application, and ... This report covers the international market analysis, including ... as the US, Europe, Asia, China, Japan etc. ...
(Date:11/21/2014)... Nov. 20, 2014 /CNW/ - Aequus Pharmaceuticals Inc. ... that it has closed a brokered private placement ... approximately C$3.7 million.  Cormark Securities Inc. and Clarus ... Brokered Offering for a syndicate of agents that ... Corp. (collectively the "Agents"). Concurrently with the Brokered ...
(Date:11/18/2014)... Nov. 18, 2014 Cord Blood Registry® (CBR®) ... the 10th Annual World Stem Cell Summit, the largest global ... 2014 World Stem Cell Summit will be held December 3-5 ... . The World Stem Cell ... lifesaving cures and therapies, convening the most prominent figures in ...
Breaking Biology Technology:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
Cached News: